Cadence Capital Management’s AngioDynamics ANGO Stock Holding History

Cadence Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-65,635	Closed	-$1.17M	–	610
2015 Q1	$1.17M	Sell	65,635 -21,250	-24%	-$395K	0.07%	357
2014 Q4	$1.65M	Buy	86,885 +5,821	+7%	+$98.6K	0.1%	271
2014 Q3	$1.11M	Sell	81,064 -2,310	-3%	-$33K	0.06%	367
2014 Q2	$1.36M	Buy	83,374 +6,125	+8%	+$88.7K	0.07%	352
2014 Q1	$1.22M	Buy	77,249 +22,579	+41%	+$368K	0.05%	409
2013 Q4	$938K	Buy	+54,670	New	+$841K	0.04%	449

Other funds holding ANGO

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMA

Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Cadence Capital Management's ANGO Position: Q2 2015 in Review

Cadence Capital Management sold out of AngioDynamics (ANGO) in Q2 2015, closing a stake of 65,635 shares — an estimated $1.17M sold.

Cadence Capital Management first reported a position in ANGO in Q4 2013 and held it in 6 quarters. The position peaked at $1.65M in Q4 2014. 116 funds tracked by Wall St. Rank hold ANGO as of Q2 2015.

Cadence Capital Management reported no remaining AngioDynamics position as of Q2 2015 after selling out during the quarter.
Cadence Capital Management sold 65,635 AngioDynamics shares in Q2 2015, an estimated $1.17M.
Cadence Capital Management first reported a position in AngioDynamics in Q4 2013 and held it in 6 quarters.
Cadence Capital Management's AngioDynamics position peaked at $1.65M in Q4 2014.
116 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2015.

Based on Cadence Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.